Intelgenx Technologies Corp Net Income per Employee (IGXT), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Intelgenx Technologies Corp   (IGXT)
 

Intelgenx Technologies Net Income per Employee

IGXT's Quarterly Results, Trends, Rankings, Statistics
Intelgenx Technologies Corp recorded a cumulative net loss of $-11 million during 12 month ending in the first quarter 2024.
The Healthcare sector has seen employees of 142 other companies achieving higher income per employee. While Intelgenx Technologies 's total ranking has deteriorated compared to the previous quarter from 0 to 3582.


What is Income per Employee Ratio?






IGXT Net Income per Employee (Mar 31 2024)
I. Quarter
(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
Y / Y Net Income Change - - - - -
Net Income per Employee (TTM) $ -367,667 -330,900 -376,367 -373,600 -364,267
IGXT's Total Ranking # 3582 # 0 # 0 # 0 #
Seq. Net Income Change - - - - -


IGXT Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 143
Healthcare Sector # 450
Overall Market # 3582

Net Income per Employee Statistics
High Average Low
$ 43,033 $ -187,613 $ -375,933
(Dec 31 2015)   (Mar 31 2024)







Companies with similar Income per Employee for 12 month ending Mar 31 2024, within Healthcare Sector Income per Employee Income 12 month ending Mar 31 2024Number of Employees Mar 31 2024


Date modified: 2026-08-29T17:27:21+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.